Encompass Health Corporation

Equities

EHC

US29261A1007

Healthcare Facilities & Services

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
82.58 USD +6.47% Intraday chart for Encompass Health Corporation +6.83% +23.77%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Barclays Raises Price Target on Encompass Health to $101 From $95, Maintains Overweight Rating MT
Encompass Health Corporation Appoints Andrew Baird as Senior Vice President of Public Policy, Legislation and Regulations CI
Transcript : Encompass Health Corporation Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 08:30 AM
Encompass Health Corp. and Piedmont Announce Plans to Build 40-Bed Inpatient Rehabilitation Hospital in Loganville, Georgia CI
Encompass Health Maintains Quarterly Dividend at $0.15 per Share, Payable April 15 to Holders of Record April 1 MT
Encompass Health Corporation Declares Quarterly Cash Dividend, Payable on April 15, 2024 CI
Encompass Health to Build 60-Bed Arizona Rehab Hospital for Severe Injury Recovery MT
Encompass Health Corporation Announces Preliminary Plans to Build a 60-Bed Inpatient Rehabilitation Hospital in Avondale, Arizona CI
UBS Adjusts Encompass Health Price Target to $88 From $84, Maintains Buy Rating MT
Mizuho Raises Price Target on Encompass Health to $82 From $77, Keeps Buy Rating MT
Deutsche Bank Adjusts Encompass Health Price Target to $83 From $77, Maintains Buy Rating MT
Transcript : Encompass Health Corporation, Q4 2023 Earnings Call, Feb 08, 2024
Encompass Health Q4 Adjusted Earnings, Revenue Rise; 2024 Outlook Set MT
Encompass Health Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Earnings Flash (EHC) ENCOMPASS HEALTH Reports Q4 EPS $0.95, vs. Street Est of $0.82 MT
Earnings Flash (EHC) ENCOMPASS HEALTH Reports Q4 Revenue $1.25B, vs. Street Est of $1.237B MT
(EHC) ENCOMPASS HEALTH Sees Fiscal Year 2024 EPS Range $3.77 - $4.06 MT
(EHC) ENCOMPASS HEALTH Forecasts Fiscal Year 2024 Revenue Range $5.2B - $5.3B MT
Encompass Health Corporation Provides Earnings Guidance for the Year 2024 CI
Encompass Health Corporation Appoints Edward M. Christie III to Its Board of Directors CI
Encompass Health Announces the Opening of Encompass Health Rehabilitation Hospital of Fitchburg CI
Encompass Health Insider Sold Shares Worth $710,919, According to a Recent SEC Filing MT
Transcript : Encompass Health Corporation, Q3 2023 Earnings Call, Oct 27, 2023
Encompass Health Q3 Adjusted Earnings, Revenue Advance; 2023 Guidance Narrowed MT
Earnings Flash (EHC) ENCOMPASS HEALTH Reports Q3 EPS $0.86, vs. Street Est of $0.77 MT
Chart Encompass Health Corporation
More charts
Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides specialized rehabilitative treatment on an inpatient basis. It operates hospitals in 37 states and Puerto Rico, with concentrations in Florida and Texas. It operates 161 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. The Company provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals also treat patients with or recovering from the COVID-19 virus. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
77.71 USD
Average target price
87.2 USD
Spread / Average Target
+12.21%
Consensus